Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

More men are getting cosmetic procedures, mainly for aging, hair loss, and to keep masculine features, with growing interest in both surgical and noninvasive treatments.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Berberine may reduce prostate enlargement by blocking inflammation.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Sex hormones affect liver fat and metabolic health differently in men and women.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride helps induce ovulation in nonresponder PCOS women.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Yak hair growth is influenced by genes and hormones, helping them adapt to alpine environments.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.